CMR Surgical closes $600M Series D at $3B valuation
CMR Surgical closed a $600 million Series D led by SoftBank Vision Fund 2 and co-led by Ally Bridge Group at a $3 billion valuation.
Evidence notes
- New investors included RPMI Railpen, Tencent and Chimera.
- LGT, Lightrock, Watrium, Cambridge Innovation Capital, PFM Health Sciences and GE Healthcare also participated.
- The capital supports global commercialization of Versius and development of CMR’s digital ecosystem.
Company context
CMR Surgical develops Versius, a modular and portable robotic system for minimal-access surgery. The Cambridge company combines independent bedside units, surgical instruments, vision and a digital ecosystem intended to help hospitals expand access to robot-assisted procedures.